229 related articles for article (PubMed ID: 33682304)
21. Lymphoplasmacytic lymphoma and Waldenström macroglobulinaemia: clinicopathological features and differential diagnosis.
Wang W; Lin P
Pathology; 2020 Jan; 52(1):6-14. PubMed ID: 31767130
[TBL] [Abstract][Full Text] [Related]
22. Discriminating between Waldenström macroglobulinemia and marginal zone lymphoma using logistic LASSO regression.
Amaador K; Vos JMI; Pals ST; Kraan W; Dobber JA; Minnema MC; Koene HR; de Bruin PC; Zwinderman AH; Kersten MJ
Leuk Lymphoma; 2022 May; 63(5):1070-1079. PubMed ID: 34961399
[TBL] [Abstract][Full Text] [Related]
23. MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma.
Martinez-Lopez A; Curiel-Olmo S; Mollejo M; Cereceda L; Martinez N; Montes-Moreno S; Almaraz C; Revert JB; Piris MA
Am J Surg Pathol; 2015 May; 39(5):644-51. PubMed ID: 25723115
[TBL] [Abstract][Full Text] [Related]
24. [The clinical features of patients with lymphoplasmacytic diseases harboring MyD88 L265P mutation].
Ren Y; Zhou BQ; Xu Y; Fu CC; Shen HJ; Ding ZX; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2016 Dec; 37(12):1054-1059. PubMed ID: 28088969
[TBL] [Abstract][Full Text] [Related]
25. Highly sensitive
Drandi D; Genuardi E; Dogliotti I; Ferrante M; Jiménez C; Guerrini F; Schirico ML; Mantoan B; Muccio V; Lia G; Zaccaria GM; Omedè P; Passera R; Orsucci L; Benevolo G; Cavallo F; Galimberti S; Sanz RG; Boccadoro M; Ladetto M; Ferrero S
Haematologica; 2018 Jun; 103(6):1029-1037. PubMed ID: 29567768
[TBL] [Abstract][Full Text] [Related]
26. Composite monoclonal B-cell lymphocytosis and MYD88 L265P-positive lymphoplasmacytic lymphoma in a patient with IgM light chain amyloidosis: Case report.
Oishi N; Inoue T; Odate T; Mochizuki K; Ohashi K; Kirito K; Kondo T
Pathol Int; 2020 Jul; 70(7):458-462. PubMed ID: 32323419
[TBL] [Abstract][Full Text] [Related]
27. MYD88 mutation analysis of a rare composite chronic lymphocyte leukemia and lymphoplasmacytic lymphoma by flow cytometry cell sorting.
Shi M; Spurgeon S; Press R; Olson S; Fan G
Ann Hematol; 2015 Nov; 94(11):1941-4. PubMed ID: 26231802
[No Abstract] [Full Text] [Related]
28. Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations.
King RL; Gonsalves WI; Ansell SM; Greipp PT; Frederick LA; Viswanatha DS; He R; Kyle RA; Gertz MA; Kapoor P; Morice WG; Howard MT
Am J Clin Pathol; 2016 Jun; 145(6):843-51. PubMed ID: 27329639
[TBL] [Abstract][Full Text] [Related]
29. A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemia.
Yang G; Zhou Y; Liu X; Xu L; Cao Y; Manning RJ; Patterson CJ; Buhrlage SJ; Gray N; Tai YT; Anderson KC; Hunter ZR; Treon SP
Blood; 2013 Aug; 122(7):1222-32. PubMed ID: 23836557
[TBL] [Abstract][Full Text] [Related]
30. Frequency of MYD88 L256P mutation and its correlation with clinico-hematological profile in mature B-cell neoplasm.
Shekhar R; Naseem S; Binota J; Varma N; Malhotra P
Hematol Oncol Stem Cell Ther; 2021 Sep; 14(3):231-239. PubMed ID: 33217360
[TBL] [Abstract][Full Text] [Related]
31. Lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia: an evolving concept.
Lin P; Medeiros LJ
Adv Anat Pathol; 2005 Sep; 12(5):246-55. PubMed ID: 16210920
[TBL] [Abstract][Full Text] [Related]
32. CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiation.
Raimbault A; Machherndl-Spandl S; Itzykson R; Clauser S; Chapuis N; Mathis S; Lauf J; Alary AS; Burroni B; Kosmider O; Fontenay M; Béné MC; Durrieu F; Bettelheim P; Bardet V
Br J Haematol; 2019 Feb; 184(4):625-633. PubMed ID: 30198568
[TBL] [Abstract][Full Text] [Related]
33. Lymphoplasmacytic lymphoma and marginal zone lymphoma in the bone marrow: paratrabecular involvement as an important distinguishing feature.
Bassarova A; Trøen G; Spetalen S; Micci F; Tierens A; Delabie J
Am J Clin Pathol; 2015 Jun; 143(6):797-806. PubMed ID: 25972321
[TBL] [Abstract][Full Text] [Related]
34. Nuclear BCL-10 expression is common in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia and does not correlate with p65 NF-kappaB activation.
Merzianu M; Jiang L; Lin P; Wang X; Weber DM; Vadhan-Raj S; Nguyen MH; Medeiros LJ; Bueso-Ramos CE
Mod Pathol; 2006 Jul; 19(7):891-8. PubMed ID: 16636680
[TBL] [Abstract][Full Text] [Related]
35. Preneoplastic somatic mutations including
Rodriguez S; Celay J; Goicoechea I; Jimenez C; Botta C; Garcia-Barchino MJ; Garces JJ; Larrayoz M; Santos S; Alignani D; Vilas-Zornoza A; Perez C; Garate S; Sarvide S; Lopez A; Reinhardt HC; Carrasco YR; Sanchez-Garcia I; Larrayoz MJ; Calasanz MJ; Panizo C; Prosper F; Lamo-Espinosa JM; Motta M; Tucci A; Sacco A; Gentile M; Duarte S; Vitoria H; Geraldes C; Paiva A; Puig N; Garcia-Sanz R; Roccaro AM; Fuerte G; San Miguel JF; Martinez-Climent JA; Paiva B
Sci Adv; 2022 Jan; 8(3):eabl4644. PubMed ID: 35044826
[TBL] [Abstract][Full Text] [Related]
36. Aggressive Lymphoplasmacytic Neoplasm With an Unusual In-frame Deletion of
Yan M; Meyerson H; Oduro KA; Shetty S; Yoest J
Int J Surg Pathol; 2024 Feb; 32(1):5-10. PubMed ID: 37093763
[TBL] [Abstract][Full Text] [Related]
37. L265P mutation of the MYD88 gene is frequent in Waldenström's macroglobulinemia and its absence in myeloma.
Mori N; Ohwashi M; Yoshinaga K; Mitsuhashi K; Tanaka N; Teramura M; Okada M; Shiseki M; Tanaka J; Motoji T
PLoS One; 2013; 8(11):e80088. PubMed ID: 24224040
[TBL] [Abstract][Full Text] [Related]
38. New treatment strategies for Waldenström macroglobulinemia.
Moreno DF; de Larrea CF; Castillo JJ
Clin Adv Hematol Oncol; 2022 Aug; 20(8):506-515. PubMed ID: 36125957
[TBL] [Abstract][Full Text] [Related]
39. Nuclear protein dysregulation in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia.
Roberts MJ; Chadburn A; Ma S; Hyjek E; Peterson LC
Am J Clin Pathol; 2013 Feb; 139(2):210-9. PubMed ID: 23355206
[TBL] [Abstract][Full Text] [Related]
40. MYD88 L265P mutation in Waldenstrom macroglobulinemia.
Poulain S; Roumier C; Decambron A; Renneville A; Herbaux C; Bertrand E; Tricot S; Daudignon A; Galiègue-Zouitina S; Soenen V; Theisen O; Grardel N; Nibourel O; Roche-Lestienne C; Quesnel B; Duthilleul P; Preudhomme C; Leleu X
Blood; 2013 May; 121(22):4504-11. PubMed ID: 23532735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]